Literature DB >> 17289218

The identification of surface proteins of Burkholderia pseudomallei.

Sarah V Harding1, Mitali Sarkar-Tyson, Sophie J Smither, Timothy P Atkins, Petra C F Oyston, Katherine A Brown, Yichun Liu, Robin Wait, Richard W Titball.   

Abstract

Burkholderia pseudomallei, the causative agent of the disease melioidosis is a human pathogen endemic in Northern Australia and South-East Asia. At present there is no available vaccine or effective treatment for this disease. Surface proteins play crucial roles in the host-pathogen interaction and have been exploited as vaccine candidates and diagnostic targets. Therefore, we wished to identify immunogenic surface proteins of B. pseudomallei. To this end we used two proteomic-based approaches in parallel: a biotinylation approach for the detection of surface located proteins identified 35 proteins, while screening with human sera identified 12 immunogenic proteins. Nine of these proteins were identified by both methods indicating that they may be both surface located and immunogenic: these proteins will be evaluated further as vaccine candidates and diagnostic targets.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17289218     DOI: 10.1016/j.vaccine.2006.12.006

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  23 in total

Review 1.  Principles of antidote pharmacology: an update on prophylaxis, post-exposure treatment recommendations and research initiatives for biological agents.

Authors:  S Ramasamy; C Q Liu; H Tran; A Gubala; P Gauci; J McAllister; T Vo
Journal:  Br J Pharmacol       Date:  2010-10       Impact factor: 8.739

Review 2.  Novel multi-component vaccine approaches for Burkholderia pseudomallei.

Authors:  L Morici; A G Torres; R W Titball
Journal:  Clin Exp Immunol       Date:  2019-04-08       Impact factor: 4.330

3.  Total protein extraction and 2-D gel electrophoresis methods for Burkholderia species.

Authors:  Billie Velapatiño; James E A Zlosnik; Trevor J Hird; David P Speert
Journal:  J Vis Exp       Date:  2013-10-15       Impact factor: 1.355

4.  Identification of Clostridium difficile Immunoreactive Spore Proteins of the Epidemic Strain R20291.

Authors:  Marjorie Pizarro-Guajardo; María Cristina Ravanal; Maria Daniela Paez; Eduardo Callegari; Daniel Paredes-Sabja
Journal:  Proteomics Clin Appl       Date:  2018-04-18       Impact factor: 3.494

5.  Flagellar glycosylation in Burkholderia pseudomallei and Burkholderia thailandensis.

Authors:  Andrew E Scott; Susan M Twine; Kelly M Fulton; Richard W Titball; Angela E Essex-Lopresti; Timothy P Atkins; Joann L Prior
Journal:  J Bacteriol       Date:  2011-05-20       Impact factor: 3.490

6.  Development of reagents and assays for the detection of pathogenic Burkholderia species.

Authors:  Omar Qazi; Mridula Rani; Annie J Gnanam; Thomas W Cullen; Christopher M Stead; Haley Kensing; Kate McCaul; Sarah Ngugi; Joann L Prior; Alexandria Lipka; Judit M Nagy; C Whitlock Gregory; Barbara M Judy; Sarah V Harding; Richard W Titball; Sachdev S Sidhu; M Stephen Trent; G Barrie Kitto; Alfredo Torres; D Mark Estes; Brent Iverson; George Georgiou; Katherine A Brown
Journal:  Faraday Discuss       Date:  2011       Impact factor: 4.008

7.  A Burkholderia pseudomallei protein microarray reveals serodiagnostic and cross-reactive antigens.

Authors:  Philip L Felgner; Matthew A Kayala; Adam Vigil; Chad Burk; Rie Nakajima-Sasaki; Jozelyn Pablo; Douglas M Molina; Siddiqua Hirst; Janet S W Chew; Dongling Wang; Gladys Tan; Melanie Duffield; Ron Yang; Julien Neel; Narisara Chantratita; Greg Bancroft; Ganjana Lertmemongkolchai; D Huw Davies; Pierre Baldi; Sharon Peacock; Richard W Titball
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-28       Impact factor: 11.205

8.  Use of Reverse Vaccinology in the Design and Construction of Nanoglycoconjugate Vaccines against Burkholderia pseudomallei.

Authors:  Laura A Muruato; Daniel Tapia; Christopher L Hatcher; Mridul Kalita; Paul J Brett; Anthony E Gregory; James E Samuel; Richard W Titball; Alfredo G Torres
Journal:  Clin Vaccine Immunol       Date:  2017-11-06

9.  S-layer, surface-accessible, and concanavalin A binding proteins of Methanosarcina acetivorans and Methanosarcina mazei.

Authors:  Deborah R Francoleon; Pinmanee Boontheung; Yanan Yang; UnMi Kin; A Jimmy Ytterberg; Patricia A Denny; Paul C Denny; Joseph A Loo; Robert P Gunsalus; Rachel R Ogorzalek Loo
Journal:  J Proteome Res       Date:  2009-04       Impact factor: 4.466

10.  Identification of Bacillus anthracis spore component antigens conserved across diverse Bacillus cereus sensu lato strains.

Authors:  Sanghamitra Mukhopadhyay; Arya Akmal; Andrew C Stewart; Ru-Ching Hsia; Timothy D Read
Journal:  Mol Cell Proteomics       Date:  2009-02-09       Impact factor: 5.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.